New cure arrives for chronic, lifelong hepatitis B infection
A new drug, Hibsago, can bring the virus to negligible levels for some patients
We haven't written up this one. Calgary Herald has the full story — the link below goes straight to it.
More in Health & Medicine
STAT+: States sue Trump administration again to delay Medicaid work requirements
The Trump administration is facing another lawsuit over its sweeping changes to Medicaid less than a week after a federal judge ruled that implementation of work requirements would cause “irreparable…
Exposed to measles? 7 steps to take, from the 72-hour vaccine window to isolation
Learn what to do if you were exposed to measles, from checking your MMR record and the 72-hour vaccine window to symptoms, testing and isolation
Which vaccines do you need to travel abroad? 7 shots and their timing
Vaccines to get before holiday travel include MMR, hepatitis A and yellow fever, and this guide explains seven shots, their dose schedules and how early to book
Seeds and preserved hair in tomb point to oldest signs of cannabis high 2,800 years ago, study suggests
Archaeologists who led a dig at a monumental tomb in Siberia said they turned up evidence of the earliest known use of cannabis for psychoactive purposes.
The Aging Proteome: Clocks, Cohorts, and Clinical Trials
In this GEN webinar, two experts will show how ultra-sensitive, multiplexed proteomics can measure both the pace of aging and the effects of interventions designed to change it.
